Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model

Agriculture & Biology

• Chlamydia trachomatis 97%
• immunogenicity 84%
• outer membrane proteins 82%
• animal models 62%
• vaccines 61%
• serotypes 61%
• ovalbumin 55%
• Chlamydia 48%
• Macaca mulatta 48%
• genitalia 23%
• monkeys 21%
• animals 19%
• mucosal immunity 16%
• subunit vaccines 16%
• antibodies 15%
• mononuclear leukocytes 13%
• neutralizing antibodies 13%
• cell-mediated immunity 13%
• adjuvants 12%
• saliva 12%
• cytokines 11%
• immune response 9%
• assays 6%

Medicine & Life Sciences

• Vaccine Immunogenicity 100%
• Chlamydia trachomatis 82%
• Primates 66%
• Serogroup 65%
• Membrane Proteins 59%
• Ovalbumin 53%
• Macaca mulatta 49%
• Chlamydia 42%
• Mucosal Immunity 29%
• Animals 23%
• Genitalia 22%
• Haplorhini 21%
• Subunit Vaccines 14%
• Antibodies 13%
• Neutralizing Antibodies 11%
• Saliva 11%
• Tears 11%
• Immunoglobulin A 11%
• Blood Cells 9%
• Immunoglobulin G 8%
• Vaccines 8%
• Cytokines 7%
• Control Groups 6%

Social Sciences

• animal 57%
• animal protein 42%
• International Sociological Association 33%
• Group 7%